11/15
08:17 am
gsk
GSK plc (NYSE: GSK) was downgraded by analysts at Deutsche Bank Aktiengesellschaft from a "buy" rating to a "hold" rating.
Low
Report
GSK plc (NYSE: GSK) was downgraded by analysts at Deutsche Bank Aktiengesellschaft from a "buy" rating to a "hold" rating.
11/12
08:03 am
gsk
GSK plc (NYSE: GSK) was downgraded by analysts at Jefferies Financial Group Inc. from a "buy" rating to a "hold" rating. They now have a $39.50 price target on the stock, down previously from $53.00.
Low
Report
GSK plc (NYSE: GSK) was downgraded by analysts at Jefferies Financial Group Inc. from a "buy" rating to a "hold" rating. They now have a $39.50 price target on the stock, down previously from $53.00.
10/31
07:10 am
gsk
GSK plc (NYSE: GSK) was downgraded by analysts at Guggenheim from a "buy" rating to a "neutral" rating.
Low
Report
GSK plc (NYSE: GSK) was downgraded by analysts at Guggenheim from a "buy" rating to a "neutral" rating.
10/26
09:32 am
gsk
GSK Q3 Earnings Preview: Shingrix And Arexvy Make The Stock A 'Strong Buy' [Seeking Alpha]
Low
Report
GSK Q3 Earnings Preview: Shingrix And Arexvy Make The Stock A 'Strong Buy' [Seeking Alpha]
10/24
07:00 am
gsk
New Data for AREXVY, GSK’s Respiratory Syncytial Virus Vaccine, Show Potential to Help Protect a Broader Group of Adults at Increased Risk for RSV Disease
Low
Report
New Data for AREXVY, GSK’s Respiratory Syncytial Virus Vaccine, Show Potential to Help Protect a Broader Group of Adults at Increased Risk for RSV Disease
10/8
07:00 am
gsk
GSK Presents Positive Data for AREXVY, Its Respiratory Syncytial Virus (RSV) Vaccine, Indicating Protection Over Three RSV Seasons
Low
Report
GSK Presents Positive Data for AREXVY, Its Respiratory Syncytial Virus (RSV) Vaccine, Indicating Protection Over Three RSV Seasons
9/18
07:00 am
gsk
GSK Announces Positive Topline Data on Co-Administration of AREXVY and SHINGRIX
Low
Report
GSK Announces Positive Topline Data on Co-Administration of AREXVY and SHINGRIX
9/16
01:04 pm
gsk
Brooke Shields Partners with GSK to Educate Adults 50 and Older About Their Shingles Risk
Low
Report
Brooke Shields Partners with GSK to Educate Adults 50 and Older About Their Shingles Risk
8/29
07:32 am
gsk
GSK plc (NYSE: GSK) was upgraded by analysts at Barclays PLC to a "hold" rating.
Low
Report
GSK plc (NYSE: GSK) was upgraded by analysts at Barclays PLC to a "hold" rating.
8/28
11:31 am
gsk
GSK plc (GSK): A Cheap Pharmaceutical Stock to Buy According to Short Sellers [Yahoo! Finance]
Low
Report
GSK plc (GSK): A Cheap Pharmaceutical Stock to Buy According to Short Sellers [Yahoo! Finance]